Anavex faces proxy fight ahead of September annual meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. HUM
8. KTOS
9. NVDA
10. CSCO

Go back to Anavex faces proxy fight ahead of September annual meeting

Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders

August 11, 2026 8:00 AM EDT

Files Definitive Proxy Statement and Mails Letter to Stockholders

Urges Stockholders to Vote "FOR" All Six Anavex Director Nominees on the WHITE Proxy Card

Underscores PVGs Lack of Clear Plan and Inexperienced Slate of Director Nominees

NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (Anavex or the Company) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system (CNS) diseases with high unmet medical needs, today announced that it has filed definitive proxy materials with the Securities and... More